Close Menu

NEW YORK (GenomeWeb) – Myriad Genetics will be ION Solutions' preferred partner for providing hereditary cancer genetic testing to its member practices, the firms announced today.

ION Solutions is an organization under AmerisourceBergen that provides expertise, technologies, and resources to more than half the community-based oncology practices in the US. Myriad markets MyRisk Hereditary Cancer, a 28-gene panel that assesses whether patients have an increased risk for eight cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.